Invention Grant
- Patent Title: Cyclopropylamine compound as LSD1 inhibitor and use thereof
-
Application No.: US17275534Application Date: 2019-09-12
-
Publication No.: US11649245B2Publication Date: 2023-05-16
- Inventor: Lingyun Wu , Qiuyan Wang , Jian Li , Shuhui Chen
- Applicant: HELIOEAST PHARMACEUTICAL CO., LTD. , Helioeast Science & Technology Co., Ltd.
- Applicant Address: CN JiangXi
- Assignee: HELIOEAST PHARMACEUTICAL CO., LTD.,Helioeast Science & Technology Co., Ltd.
- Current Assignee: HELIOEAST PHARMACEUTICAL CO., LTD.,Helioeast Science & Technology Co., Ltd.
- Current Assignee Address: CN Nanchang; CN Nanchang
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: CN 1811070319.6 2018.09.13 CN 1910100629.6 2019.01.31
- International Application: PCT/CN2019/105683 2019.09.12
- International Announcement: WO2020/052649A 2020.03.19
- Date entered country: 2021-03-11
- Main IPC: C07D491/107
- IPC: C07D491/107
Abstract:
Provided is a cyclopropylamine compound as lysine-specific demethylase 1 (LSD1) inhibitor, and a use thereof in preparation of drug for treating diseases associated with LSD1. The cyclopropylamine compound is a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20220119401A1 CYCLOPROPYLAMINE COMPOUND AS LSD1 INHIBITOR AND USE THEREOF Public/Granted day:2022-04-21
Information query
